Amgen Inc (AMGN)vsWalt Disney Company (DIS)
AMGN
Amgen Inc
$331.70
+0.79%
HEALTHCARE · Cap: $177.71B
DIS
Walt Disney Company
$108.02
-0.59%
COMMUNICATION SERVICES · Cap: $188.69B
Smart Verdict
WallStSmart Research — data-driven comparison
Walt Disney Company generates 161% more annual revenue ($97.26B vs $37.22B). AMGN leads profitability with a 21.0% profit margin vs 11.5%. AMGN appears more attractively valued with a PEG of 2.18. AMGN earns a higher WallStSmart Score of 62/100 (C+).
AMGN
Buy62
out of 100
Grade: C+
DIS
Buy57
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-2.2%
Fair Value
$321.89
Current Price
$331.70
$9.81 premium
Margin of Safety
+16.1%
Fair Value
$126.48
Current Price
$108.02
$18.46 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 101 in profit
Strong operational efficiency at 33.8%
Large-cap with strong market position
Keeps 21 of every $100 in revenue as profit
Generating 1.5B in free cash flow
Large-cap with strong market position
Attractively priced relative to earnings
Reasonable price relative to book value
Generating 4.9B in free cash flow
Areas to Watch
Expensive relative to growth rate
Trading at 19.5x book value
4.4% earnings growth
Grey zone — moderate risk
Expensive relative to growth rate
Earnings declined 29.8%
Comparative Analysis Report
WallStSmart ResearchBull Case : AMGN
The strongest argument for AMGN centers on Return on Equity, Operating Margin, Market Cap. Profitability is solid with margins at 21.0% and operating margin at 33.8%.
Bull Case : DIS
The strongest argument for DIS centers on Market Cap, P/E Ratio, Price/Book.
Bear Case : AMGN
The primary concerns for AMGN are PEG Ratio, Price/Book, EPS Growth.
Bear Case : DIS
The primary concerns for DIS are Altman Z-Score, PEG Ratio, EPS Growth.
Key Dynamics to Monitor
AMGN profiles as a mature stock while DIS is a value play — different risk/reward profiles.
DIS carries more volatility with a beta of 1.42 — expect wider price swings.
DIS is growing revenue faster at 6.5% — sustainability is the question.
DIS generates stronger free cash flow (4.9B), providing more financial flexibility.
Bottom Line
AMGN scores higher overall (62/100 vs 57/100), backed by strong 21.0% margins. DIS offers better value entry with a 16.1% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Amgen Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
Visit Website →Walt Disney Company
COMMUNICATION SERVICES · ENTERTAINMENT · USA
The Walt Disney Company, commonly known as Disney, is an American diversified multinational mass media and entertainment conglomerate headquartered at the Walt Disney Studios complex in Burbank, California.
Visit Website →Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?